| The pulmonary embolism risk score system reduces the incidence and mortality of pulmonary embolism after gastric bypass. | |
| | |
MedLine Citation:
|
PMID: 19789027 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Pulmonary embolism (PE) is a leading cause of death after roux-en-Y gastric bypass (RYGB); therefore, current recommendations for prophylaxis may be inadequate. METHODS: We reviewed our first 1,341 patients (controls) who underwent RYGB and weighted factors that may have contributed to PE to arrive at a pulmonary embolism risk score (PERS). We postulated that more aggressive prophylaxis in higher risk patients might have reduced the incidence of PE. We tested our hypothesis by basing prophylaxis on the PERS in 1,652 subsequent RYGB patients (study group). Standard risk patients (PERS <4) were ambulated 2 hours after surgery, had application of intermittent compression devices, and received subcutaneous low-dose, unfractionated heparin (LDUH). Intermediate risk patients (PERS = 4) received standard prophylaxis and 3 weeks of postdischarge LDUH. High-risk patients (PERS >4) had postdischarge LDUH and a preoperative vena cava filter. RESULTS: The 0.36% incidence of PE (6 patients) in the study group was significantly lower (P <.05) than the 1% incidence (13 patients) in the controls. Three of 189 men in the control group died of PE, whereas there were no deaths from PE in 271 men in the study group (P <.05). CONCLUSION: The PERS may be an appropriate scoring system for determining preoperatively the level of risk for postoperative PE in RYGB patients. Basing prophylaxis on the level of risk reduces the incidence and mortality of PE and consumes resources judiciously. |
| | |
Authors:
|
Joseph A Caruana; Paul M Anain; Dang Tuan Pham |
Related Documents
:
|
20682597 - Different effects of enoxaparin, nadroparin, and dalteparin on plasma tfpi during hemod... 20124617 - Deep vein thrombosis in acute myelogenous leukemia. 17402557 - Repetitive miscarriages in a patient with a high level of anticardiolipin antibodies an... 10339707 - Puerperal cerebral venous thrombosis: therapeutic benefit of low dose heparin. 18674497 - Simple criteria to assess mortality in patients with community-acquired pneumonia. 16466057 - Risk factors for defaulting from tuberculosis treatment: a prospective cohort study of ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Surgery Volume: 146 ISSN: 1532-7361 ISO Abbreviation: Surgery Publication Date: 2009 Oct |
Date Detail:
|
Created Date: 2009-09-30 Completed Date: 2009-10-14 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0417347 Medline TA: Surgery Country: United States |
Other Details:
|
Languages: eng Pagination: 678-83; discussion 683-5 Citation Subset: AIM; IM |
Affiliation:
|
Department of Surgery, Sisters of Charity Hospital and the State University of New York at Buffalo, Buffalo, NY 14221, USA. jcaruanamd@SynergyBariatrics.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Female Gastric Bypass / adverse effects* Heparin / therapeutic use Humans Male Middle Aged Postoperative Complications / prevention & control* Pulmonary Embolism / epidemiology, mortality, prevention & control* Retrospective Studies Venous Thromboembolism / prevention & control |
| Chemical | |
Reg. No./Substance:
|
9005-49-6/Heparin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A single institutional experience of factors affecting successful identification of sentinel lymph n...
Next Document: Single center experience transplanting kidneys from deceased donors with terminal acute renal failur...